1. Home
  2. FOCL vs DHY Comparison

FOCL vs DHY Comparison

Compare FOCL & DHY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo EDAP TMS S.A. American Depositary Shares

FOCL

EDAP TMS S.A. American Depositary Shares

N/A

Current Price

$2.96

Market Cap

206.3M

Sector

Health Care

ML Signal

N/A

DHY

Credit Suisse High Yield Bond Fund

N/A

Current Price

$16.32

Market Cap

240.4M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
FOCL
DHY
Founded
1979
N/A
Country
France
United States
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Finance/Investors Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
206.3M
240.4M
IPO Year
1998
1998

Fundamental Metrics

Financial Performance
Metric
FOCL
DHY
Price
$2.96
$16.32
Analyst Decision
Buy
Analyst Count
5
0
Target Price
★ $8.30
N/A
AVG Volume (30 Days)
★ 60.6K
52.3K
Earning Date
11-05-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
★ $70,527,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$33.55
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 1.63
N/A
52 Week Low
$2.80
$1.61
52 Week High
$6.40
$17.05

Technical Indicators

Market Signals
Indicator
FOCL
DHY
Relative Strength Index (RSI) 30.83 66.10
Support Level N/A $15.90
Resistance Level $4.56 $16.38
Average True Range (ATR) 0.31 0.22
MACD -0.10 -0.40
Stochastic Oscillator 9.20 27.00

Price Performance

Historical Comparison
FOCL
DHY

About FOCL EDAP TMS S.A. American Depositary Shares

Edap TMS SA, formerly known as FocalTherics, operates in the Robotic Focal Therapy industry. It develops, manufactures, and markets minimally invasive medical devices across various countries to treat various conditions using proprietary focused ultrasound technology. The company's flagship platform, Focal One Robotic HIFU, combines imaging, real-time treatment planning, robotic precision, and high intensity focused ultrasound (HIFU) technology. It is focused on expanding the clinical adoption of its patented focused ultrasound-based robotic therapy platforms through continued innovation, clinical evidence generation, physician education, and various market development initiatives.

About DHY Credit Suisse High Yield Bond Fund

Credit Suisse High Yield Credit Fund is a diversified, closed-end management investment company. The Fund's principal investment objective is to generate current income. Capital appreciation is a secondary objective, pursued to the extent consistent with the Fund's primary income objective.

Share on Social Networks: